In the spring-time of his voodoo... I remember the lyrics from a Tori Amos song... April, May, June are the harbingers of blossom and a new period of vegetation - I can see it on my front-porch and garden. Planting the seeds or trees to become tomorrow's source of pleasure. Likewise, you and I might have done some digital transformation gardening at Bayer. Be it connecting ophthalmology to VR or blockchain via POAP Studio, pushing a modern web approach, furthering customer segmentation and enhancing event lead generation, or helping Hemophilia colleagues and HCPs worldwide to benefit from onboarding trainings and patients to engage in managing their PK-levels even better. Or even supporting Health&Wellbeing initiatives in Leverkusen. All, while navigating the insecurities and possibilities of a new #DSO world within the company. As Digital Transformation Lead for Bayer Pharma, Stefankai supports Global Hemophilia and Ophthalmology commercial and medical functions with advice and end-to-end responsibility on activities how to leverage digital in our markets for furthering our vision of Health for all, Hunger for none. You received this POAP after you met Stefankai virtually or in person, via e-mail, QR code or by tapping your phone on the IYK disc or card – a cool way to claim POAPs. #TurningPoint #TeamBayer #Humanocracy #POAP #VR #apostleofyeysus #stefankai.eth Image created with Midjourney and Canva Collection: https://collections.poap.xyz/stefankai-designs-2023

In January 2024, EYLEA 8mg achieved new heights in Bayer’s mission of 'helping patients see a better life'. You celebrated this major milestone in the EYLEA journey by attending the EYLEA 8mg Global Townhall on January 16, 2024. Either in person in Basel or virtually worldwide. You met the hosts Jan Voss and Zoran Hasanbasic (EYLEA IPT Leads) and the full cross-functional team and learned what they achieved to bring EYLEA 8mg to market, also what the real benefit means to patients and their caregivers. Anne-Grethe Mortensen, Mike Devoy and Stefan Oelrich brought their perspectives and spoke about what this success-story meant to the Pharma division and to the company as a whole. https://www.bayer.com/poap